Come March, the patent for semaglutide - the active ingredient in Ozempic and Wegovy - expires here, potentially unleashing a flood of cheaper generics and making them more accessible
No, at the moment, only brand-name versions of dulaglutide and tirzepatide are approved by the FDA
Melanotan II & PT-141 Stack Dosage Protocol Melanocortin agonists Melanotan II (tanning) + PT-141/bremelanotide (libido)
doi: 10.1146/annurev.nutr.20.1.153, PMID: [DOI] [PubMed] [Google Scholar] 45
Most evidence is preclinical, so patients should avoid treating these research themes as guaranteed clinical outcomes
Similarly, an accessible compounded sublingual option doesn't serve someone who requires FDA clinical trial data for their comfort level